CN107412388A - 一种中药外敷祛痘膏 - Google Patents
一种中药外敷祛痘膏 Download PDFInfo
- Publication number
- CN107412388A CN107412388A CN201710720769.4A CN201710720769A CN107412388A CN 107412388 A CN107412388 A CN 107412388A CN 201710720769 A CN201710720769 A CN 201710720769A CN 107412388 A CN107412388 A CN 107412388A
- Authority
- CN
- China
- Prior art keywords
- grams
- external application
- chinese medicine
- skin
- decoction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 18
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 14
- 235000018958 Gardenia augusta Nutrition 0.000 claims abstract description 14
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 13
- 244000124853 Perilla frutescens Species 0.000 claims abstract description 13
- 240000007164 Salvia officinalis Species 0.000 claims abstract description 13
- 235000005412 red sage Nutrition 0.000 claims abstract description 13
- 235000012907 honey Nutrition 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000004615 ingredient Substances 0.000 claims description 4
- 239000002674 ointment Substances 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 3
- 230000008030 elimination Effects 0.000 claims description 3
- 238000003379 elimination reaction Methods 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims 2
- 239000010931 gold Substances 0.000 claims 2
- 229910052737 gold Inorganic materials 0.000 claims 2
- 241000256844 Apis mellifera Species 0.000 claims 1
- 239000002893 slag Substances 0.000 claims 1
- 231100000241 scar Toxicity 0.000 abstract description 11
- 208000002874 Acne Vulgaris Diseases 0.000 abstract description 9
- 206010000496 acne Diseases 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 6
- 230000026535 de-etiolation Effects 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 3
- 241000894006 Bacteria Species 0.000 abstract description 2
- 238000004140 cleaning Methods 0.000 abstract description 2
- 210000003205 muscle Anatomy 0.000 abstract description 2
- 239000011148 porous material Substances 0.000 abstract description 2
- 238000007670 refining Methods 0.000 abstract description 2
- 230000036737 immune function Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 20
- 206010061218 Inflammation Diseases 0.000 description 4
- 241000700647 Variola virus Species 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 210000004927 skin cell Anatomy 0.000 description 3
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 2
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 2
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 2
- 241001480043 Arthrodermataceae Species 0.000 description 2
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 2
- XJMPAUZQVRGFRE-SCHFUKFYSA-N Gardenoside Natural products O=C(OC)C=1[C@H]2[C@H]([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)[C@@](O)(CO)C=C2 XJMPAUZQVRGFRE-SCHFUKFYSA-N 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000037304 dermatophytes Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- 230000028709 inflammatory response Effects 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- XJMPAUZQVRGFRE-AYDWLWLASA-N methyl (1s,4as,7s,7as)-7-hydroxy-7-(hydroxymethyl)-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,7a-dihydro-1h-cyclopenta[c]pyran-4-carboxylate Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1[C@](C=C2)(O)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XJMPAUZQVRGFRE-AYDWLWLASA-N 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- XDQITMCFPPPMBC-TUANDBMESA-N scutelloside Natural products OC[C@H]1O[C@@H](O[C@@H]2O[C@@H]3C[C@H]4[C@H](O)[C@@H](O)[C@@](O)(CO3)[C@@H]24)[C@H](O)[C@@H](O)[C@@H]1O XDQITMCFPPPMBC-TUANDBMESA-N 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 229950005143 sitosterol Drugs 0.000 description 2
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 2
- 235000015500 sitosterol Nutrition 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 241000186427 Cutibacterium acnes Species 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- IBFYXTRXDNAPMM-BVTMAQQCSA-N Geniposide Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1C(=CC2)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O IBFYXTRXDNAPMM-BVTMAQQCSA-N 0.000 description 1
- IBFYXTRXDNAPMM-FZEIBHLUSA-N Geniposide Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)[C@H]2[C@@H]1CC=C2CO IBFYXTRXDNAPMM-FZEIBHLUSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- 208000002260 Keloid Diseases 0.000 description 1
- 206010023330 Keloid scar Diseases 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- HKOIDIVCPUDLBS-UHFFFAOYSA-N Skullcapflavone II Natural products Oc1cccc(O)c1C2=CC(=O)c3c(O)c(O)c(O)c(O)c3O2 HKOIDIVCPUDLBS-UHFFFAOYSA-N 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- HIMJIPRMECETLJ-UHFFFAOYSA-N Wogonin Natural products COc1cc(O)c(O)c2C(=O)C=C(Oc12)c3ccccc3 HIMJIPRMECETLJ-UHFFFAOYSA-N 0.000 description 1
- LNOHXHDWGCMVCO-UHFFFAOYSA-N Wogonoside Natural products C1=C(O)C(C(C=C(O2)C=3C=CC=CC=3)=O)=C2C(OC)=C1OC1OC(C(O)=O)C(O)C(O)C1O LNOHXHDWGCMVCO-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- VGLLGNISLBPZNL-RBUKDIBWSA-N arborescoside Natural products O=C(OC)C=1[C@@H]2C([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)=C(CO)CC2 VGLLGNISLBPZNL-RBUKDIBWSA-N 0.000 description 1
- 210000000979 axoneme Anatomy 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000013532 brandy Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229930182489 iridoid glycoside Natural products 0.000 description 1
- 150000008145 iridoid glycosides Chemical class 0.000 description 1
- 210000001117 keloid Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000002926 oxygen Chemical class 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229940055019 propionibacterium acne Drugs 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- GMQFOKBGMKVUQZ-UHFFFAOYSA-N scullcapflavone II Chemical compound COC1=CC=CC(O)=C1C1=CC(=O)C2=C(O)C(OC)=C(OC)C(OC)=C2O1 GMQFOKBGMKVUQZ-UHFFFAOYSA-N 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- XLTFNNCXVBYBSX-UHFFFAOYSA-N wogonin Chemical compound COC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=CC=C1 XLTFNNCXVBYBSX-UHFFFAOYSA-N 0.000 description 1
- LNOHXHDWGCMVCO-NTKSAMNMSA-N wogonin 7-O-beta-D-glucuronide Chemical compound C1=C(O)C(C(C=C(O2)C=3C=CC=CC=3)=O)=C2C(OC)=C1O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LNOHXHDWGCMVCO-NTKSAMNMSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Insects & Arthropods (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明提供一种中药外敷祛痘膏，属于护肤领域，包括丹参10‑15克、黄芩15‑20克、栀子15‑20克、金银花15‑20克、白苏10‑15克，蜂蜜10‑15克。通过对各种物质进行调配，调和成膏状外敷在脸上，进而去除皮肤上的痘疤痘痕，去除造成疤痕的细菌，去黄去皱去黄，增强皮肤免疫功能，滋养皮肤，起到使肌肤白皙光滑，去除疤痕，收缩毛孔,调整皮肤纹理，清洁皮肤的作用。
Description
技术领域
本发明涉及护肤领域，特别是涉及一种中药外敷祛痘膏。
背景技术
现代女性对于美丽的追求是无穷无尽的，但是在追求美的同时，更注重对于皮肤的保养。
痘痕是机体对组织损伤产生的一种修复反应，当皮肤的损伤深及真皮或大面积的表皮缺损，该部位的表皮不能再生，将由真皮纤维细胞，胶原以及增生的血管所取代，这样就出现了痘痕。痘痕是因为感染发炎或外力挤压所形成，往往是因为在青春痘发作时没有得到及时适当的治疗，皮肤细胞的发炎反应造成了对皮肤组织的破坏，造成了疤痕的产生。由于青春痘的种类各式各样，所以青春痘痕的形式也有好多种，而青春痘发作时的发炎反应越严重，皮肤组织也破坏得越厉害；发炎的部位越深，皮肤组织被破坏得也越深，将来可能留下的痘痕也就越严重。
痘痘发作时引起血管扩张，痘痘消下去后血管并不会马上缩下去，就形成了一些平平红红的红斑，而皮肤细胞的发炎反应造成了对皮肤组织的破坏，发炎后的色素沉淀会使长过红痘痘的地方留下黑黑脏脏的颜色，这样就形成了痘印；而当痘痘持续痘印也不断增多的时候，各种细胞释放出多种细胞因子，导致皮肤胶原和基质排列异常，再加上微循环和自由基因素的影响，淋巴回流减少，局部水肿，这就形成了痘疤痘痕。一旦当初挤压不当伤及真皮层，形成的皮肤凹洞实际上是一种轻微的疤痕，是永久性的。
发明内容
本发明提供一种中药外敷祛痘膏，解决现有的挤压不当伤及真皮层，形成的皮肤凹洞所造成的一种轻微的疤痕，也就是痘印。
本发明通过以下技术方案解决上述问题：
一种中药外敷祛痘膏，包括丹参10-15克、黄芩15-20克、栀子15-20克、金银花15-20克、白苏10-15克，蜂蜜10-15克；所述丹参、黄芩、栀子、金银花，白苏需用清水浸泡2小时；所述丹参、黄芩、栀子、金银花、白苏浸泡2小时后连带浸泡的水一起煮沸，煮沸后滤去药渣；所述的滤去药渣的汤药用小火慢熬，熬至膏状；所述的药膏晾凉后加入蜂蜜调和。
所述丹参具有清心安神，治心神不安之证。本品活血、凉血，能祛斑、祛瘢痕。在美容用药上，尤为损容性疾病所多用。本品用于粉刺、酒渣鼻、面斑、瘢痕疙瘩等病，亦以血瘀有热者为宜。
所述的黄芩含有黄芩苷、汉黄芩素、汉黄芩苷、黄芩新素等黄酮类，氨基酸，挥发油，以及葡萄糖、蔗糖、p-谷甾醇等。黄芩煎剂有较广的抗菌谱，对多种皮肤致病性真菌，均有抑制作用，并有抗炎、抗变态反应作用。具有抗氧化作用，能清除氧自由基，能显著抑制过氧化脂质的生成，延长皮肤细胞寿命，增强抗衰老的能力。并能吸收紫外线，具抗过敏作用，对于已晒伤的皮肤，有一定修复作用。黄芩苷能抑制痤疮丙酸杆菌，且能有效地清除囊肿型痤疮里的死亡细胞、死亡菌体及其他残余物，加速痤疮的痊愈，且愈后不易留下斑痕。
所述的栀子含异栀子苷、京尼平苷、栀子苷、栀子酮苷、京尼平苷酸等环烯醚萜苷类，以及有机酸类、色素类、甘露醇、谷甾醇、熊果酸等。对溶血性链球菌和多种皮肤真菌有抑制作用。有降压、止血、降血脂作用。其提取物制成油膏，可加速软组织的愈合。
所述的金银花含环己六醇、黄酮类、肌醇、皂苷、鞣质等。叶含黄醇素、鞣质；茎含皂苷等。具有广谱抗菌作用，对金黄色葡萄球菌、溶血性链球菌、肺炎球菌、痢疾杆菌等致病菌有较强的抑制作用，对钩端螺旋体、流感病毒及某些皮肤真菌等多种病原微生物均有抑制作用。有明显抗炎及解热作用。本品所含木犀草素，能达皮层深处，抑制透明质酸酶活性，抑制和消除皮肤色斑的形成。
所述的白苏适合干燥、起皱、灰黄的皮肤。
本发明的优点与效果是：
本发明提供一种中药外敷祛痘膏，通过对各种物质进行调配，调和成膏状外敷在脸上，进而去除皮肤上的痘疤痘痕，去除造成疤痕的细菌，去黄去皱去黄，增强皮肤免疫功能，滋养皮肤，起到使肌肤白皙光滑，去除疤痕，收缩毛孔,调整皮肤纹理，清洁皮肤的作用。
具体实施方式
以下结合实施例对本发明作进一步说明。
一种中药外敷祛痘膏，包括丹参10克、黄芩15克、栀子15克、金银花15克、白苏10克，蜂蜜10克；
一种中药外敷祛痘膏，包括丹参15克、黄芩20克、栀子20克、金银花20克、白苏15克，蜂蜜15克；
一种中药外敷祛痘膏，包括丹参12克、黄芩18克、栀子15克、金银花20克、白苏15克，蜂蜜15克；
以上已对本发明创造的较佳实施例进行了具体说明，但本发明并不限于实施例，熟悉本领域的技术人员在不违背本发明创造精神的前提下还可作出种种的等同的变型或替换，这些同等的变型或替换均包含在本申请的范围内。
Claims (6)
1.一种中药外敷祛痘膏，包括丹参10-15克、黄芩15-20克、栀子15-20克、金银花15-20克、白苏10-15克，蜂蜜10-15克；所述丹参、黄芩、栀子、金银花，白苏需用清水浸泡2小时；所述丹参、黄芩、栀子、金银花、白苏浸泡2小时后连带浸泡的水一起煮沸，煮沸后滤去药渣；所述的滤去药渣的汤药用小火慢熬，熬至膏状；所述的药膏晾凉后加入蜂蜜调和。
2.根据权利要求1所述的一种中药外敷祛痘膏，其特征在于：所述丹参、黄芩、栀子、金银花，白苏需用清水浸泡2小时。
3.根据权利要求2所述的一种中药外敷祛痘膏，其特征在于：所述丹参、黄芩、栀子、金银花、白苏浸泡2小时后连带浸泡的水一起煮沸。
4.根据权利要求3所述的一种中药外敷祛痘膏，其特征在于：所述的汤药煮沸后滤去药渣。
5.根据权利要求4所述的一种中药外敷祛痘膏，其特征在于：所述的滤去药渣的汤药用小火慢熬，熬至膏状。
6.根据权利要求5所述的一种中药外敷祛痘膏，其特征在于：所述的药膏晾凉后加入蜂蜜调和。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710720769.4A CN107412388A (zh) | 2017-08-22 | 2017-08-22 | 一种中药外敷祛痘膏 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710720769.4A CN107412388A (zh) | 2017-08-22 | 2017-08-22 | 一种中药外敷祛痘膏 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107412388A true CN107412388A (zh) | 2017-12-01 |
Family
ID=60433807
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710720769.4A Pending CN107412388A (zh) | 2017-08-22 | 2017-08-22 | 一种中药外敷祛痘膏 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107412388A (zh) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20100089409A (ko) * | 2009-02-03 | 2010-08-12 | 제노마인(주) | 여드름 개선용 화장료 조성물 |
| CN105362176A (zh) * | 2015-11-12 | 2016-03-02 | 重庆维可健康咨询有限公司 | 一种祛痘膏 |
| CN106361942A (zh) * | 2016-08-31 | 2017-02-01 | 黄爱满 | 一种祛痘膏及其制备方法 |
| CN106943321A (zh) * | 2017-04-20 | 2017-07-14 | 唐凯琪 | 一种中药外敷祛痘膏 |
-
2017
- 2017-08-22 CN CN201710720769.4A patent/CN107412388A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20100089409A (ko) * | 2009-02-03 | 2010-08-12 | 제노마인(주) | 여드름 개선용 화장료 조성물 |
| CN105362176A (zh) * | 2015-11-12 | 2016-03-02 | 重庆维可健康咨询有限公司 | 一种祛痘膏 |
| CN106361942A (zh) * | 2016-08-31 | 2017-02-01 | 黄爱满 | 一种祛痘膏及其制备方法 |
| CN106943321A (zh) * | 2017-04-20 | 2017-07-14 | 唐凯琪 | 一种中药外敷祛痘膏 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104825351B (zh) | 一种沉香美白洗面奶及其制备方法 | |
| CN106943321A (zh) | 一种中药外敷祛痘膏 | |
| CN107737041A (zh) | 一种新型皮肤抗敏修护组合物、皮肤修复霜及其制备方法 | |
| CN104434757A (zh) | 双氧新活面膜 | |
| CN104248522A (zh) | 植物精华爽肤水 | |
| CN107184647A (zh) | 一种中药外敷祛疤膏 | |
| CN104327972A (zh) | 一种紫草祛痘皂 | |
| CN104116672A (zh) | 一种复方天然面膜及其制备方法 | |
| CN109044947A (zh) | 一种铁皮石斛祛痘面膜及其制备方法 | |
| CN105078865A (zh) | 一种祛痘面膜及其制备方法 | |
| CN107412388A (zh) | 一种中药外敷祛痘膏 | |
| CN105411994A (zh) | 一种含有银杏提取物、金盏菊提取物和灵芝提取物的美白化妆品 | |
| CN107375154A (zh) | 一种祛斑净白组合物及其制备方法 | |
| CN104414954A (zh) | 蜗牛调敏霜 | |
| CN106367246A (zh) | 一种沉香珍珠古皂及其制备方法 | |
| CN108624426A (zh) | 一种抑菌保湿艾草凝脂冷制精油皂及其加工工艺 | |
| CN108355125A (zh) | 一种防皲裂药膏及其制备方法 | |
| CN108685805A (zh) | 一种养颜美容艾碳中药面膜及其制备方法与应用 | |
| CN107115232A (zh) | 一种应用于化妆品的提神舒缓液 | |
| CN108379529A (zh) | 一种腰肾保养精油及其制作方法 | |
| CN107281057A (zh) | 一种祛痘淡斑面膜及其制备方法 | |
| CN108619410A (zh) | 一种艾山灵艾艾草精油及其提取工艺 | |
| CN106540051B (zh) | 治疗鼻炎的中药组合物、粉剂和膏剂及其制备方法 | |
| CN102335109A (zh) | 一种植物杀菌除螨洁面乳 | |
| CN110464685A (zh) | 一种含有细胞修复因子的沉香赋活眼霜 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20171201 |